###begin article-title 0
Polymorphisms in the selenoprotein S gene: lack of association with autoimmune inflammatory diseases
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 139 150 139 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1/SelS </italic>
###xml 363 369 356 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
###xml 456 462 449 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
Selenoprotein S (SelS) protects the functional integrity of the endoplasmic reticulum against the deleterious effects of metabolic stress. SEPS1/SelS polymorphisms have been involved in the increased release of pro-inflammatory cytokines interleukin (IL)-1beta, tumor necrosis factor (TNF)-alpha and IL-6 in macrophages. We aimed at investigating the role of the SEPS1 variants previously associated with higher plasma levels of these cytokines and of the SEPS1 haplotypes in the susceptibility to develop immune-mediated diseases characterized by an inflammatory component.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 42 48 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
###xml 167 175 <span type="species:ncbi:9606">patients</span>
Six polymorphisms distributed through the SEPS1 gene (rs11327127, rs28665122, rs4965814, rs12917258, rs4965373 and rs2101171) were genotyped in more than two thousand patients suffering from type 1 diabetes, rheumatoid arthritis or inflammatory bowel diseases and 550 healthy controls included in the case-control study.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 23 29 23 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
Lack of association of SEPS1 polymorphisms or haplotypes precludes a major role of this gene increasing predisposition to these inflammatory diseases.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1</italic>
###xml 219 220 219 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 429 430 429 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 500 506 500 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
###xml 635 636 628 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 747 753 740 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
###xml 1015 1020 1008 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1</italic>
###xml 1068 1069 1061 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human gene SEPS1, located on chromosome 15q26.3, encodes selenoprotein S which participates in the retro-translocation of misfolded proteins from the endoplasmic reticulum (ER) to the cytosol for their degradation [1]. This ER membrane protein functions in stress responses to prevent the deleterious consequences of accumulation of misfolded proteins, accumulation that has been linked to immune and inflammatory processes [2]. A study identified the strong association of the proximal promoter SEPS1 polymorphism at -105G/A with circulating levels of three pro-inflammatory cytokines, interleukin (IL)-6, IL-1beta and TNF-alpha [3]. Moreover, these authors reported that the mutant variant significantly reduced the promoter activity of the SEPS1 gene in stressed HepG2 cells and that the suppression of this gene by short interfering RNA increased the release of pro-inflammatory cytokines in a macrophage cell line. A regulatory loop has been recently proposed whereby cytokines stimulate the expression of SEPS1, which in turn diminishes cytokine production [4].
###end p 9
###begin p 10
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
###xml 50 56 50 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tanis </italic>
###xml 104 105 104 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 434 435 434 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 436 437 436 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 695 697 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 4 10 <span type="species:ncbi:10090">murine</span>
###xml 31 36 <span type="species:ncbi:9606">human</span>
The murine homolog gene of the human SEPS1 is the Tanis gene, which encodes a serum amyloid A receptor [5]. Acute phase serum amyloid A proteins (SAAs) are multifunctional apolipoproteins produced in large amounts during the acute phase of inflammation and also during the development of chronic inflammatory diseases. SAAs are involved in the pathogenesis of several chronic inflammatory diseases, such as rheumatoid arthritis (RA) [6-9], multiple sclerosis (MS)[10] and inflammatory bowel diseases (IBD) [11-13]. It is believed that locally synthesized SAA by synovial cells in the inflamed joints acts as an autocrine inducer of matrix metalloproteinase-1 and causes extensive joint erosion [14].
###end p 10
###begin p 11
###xml 129 135 129 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
###xml 343 349 343 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
###xml 371 379 371 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 406 415 406 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 480 481 480 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 591 593 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 632 638 632 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
###xml 714 722 <span type="species:ncbi:9606">patients</span>
Altogether these data point to the important role of selenoprotein S mediating inflammation, and we aimed at testing whether the SEPS1 gene was involved in the development of inflammatory autoimmune complex diseases. These are multifactorial traits influenced by both genetic predisposing factors and environmental triggers. The activation of SEPS1 expression by fasting in vivo and by glucose-deprivation in vitro allowed its assignation to the glucose-regulated protein family [5,15]. Furthermore, a locus on 15q26, IDDM3, was described to increase susceptibility to type 1 diabetes, T1D [16,17]. Therefore, we decide to test the SEPS1 polymorphisms for association with diabetes risk in a cohort of Spanish T1D patients. Additionally, we pursued to study two other autoimmune diseases with an important inflammatory component, rheumatoid arthritis and the inflammatory bowel diseases, Crohn's disease (CD) and ulcerative colitis (UC). Provided this candidate gene previously related with the inflammatory response shows any influence on the pathogenesis of these diseases, a new mechanistic tool for treatment would be available.
###end p 11
###begin title 12
Methods
###end title 12
###begin title 13
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and controls
###end title 13
###begin p 14
###xml 67 75 <span type="species:ncbi:9606">patients</span>
The study group consisted of 592 RA, 674 IBD and 311 T1D unrelated patients, consecutively recruited from one centre, either Hospital Clinico San Carlos or Hospital Ramon y Cajal (Madrid, Spain).
###end p 14
###begin p 15
###xml 4 12 <span type="species:ncbi:9606">patients</span>
T1D patients (median age at onset 15 years) diagnosed according to the criteria of the American Diabetes Association (ADA), were insulin-dependent at the time to study.
###end p 15
###begin p 16
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 197 205 <span type="species:ncbi:9606">patients</span>
###xml 253 261 <span type="species:ncbi:9606">patients</span>
###xml 370 378 <span type="species:ncbi:9606">patients</span>
RA diagnosis was established based on the American College of Rheumatology (ACR) criteria [18] and samples were previously genotyped for HLA-DRB1. Mean age at onset was 54 +/- 14 years; 61% of the patients carried the shared epitope; 66% and 50% of the patients were positive for rheumatoid factor and for anti-cyclic citrullinated peptide, respectively, and 32% of the patients presented nodular disease.
###end p 16
###begin p 17
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 17 25 <span type="species:ncbi:9606">patients</span>
###xml 140 148 <span type="species:ncbi:9606">patients</span>
###xml 174 182 <span type="species:ncbi:9606">patients</span>
###xml 224 232 <span type="species:ncbi:9606">patients</span>
###xml 305 313 <span type="species:ncbi:9606">patients</span>
###xml 607 615 <span type="species:ncbi:9606">patients</span>
Diagnosis of IBD patients was based on standard clinical, radiologic, endoscopic and histologic criteria [19]. The mean age at onset for UC patients was 38 years; 41% of the patients presented pancolitis; 47% and 13% of the patients suffered extraintestinal manifestations and colectomy, respectively. CD patients were classified according to the location of the lesions in ileal (L1, 48%), colonic (L2, 16%), ileocolonic (L3, 32%) and upper gastrointestinal tract (L4, 3%) and according to the disease behavior in inflammatory (B1, 43%), stricturing (B2, 15%) and perforating (B3, 42%). Only 20% of the CD patients debuted after the age of 40.
###end p 17
###begin p 18
A group of 550 healthy unrelated subjects from Madrid (mainly hospital employees and blood donors) were selected as controls. Cases and controls were all white Spanish subjects and were included in this study after written informed consent. The Ethics Committee of Hospital Clinico (Madrid) approved the study.
###end p 18
###begin title 19
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
SEPS1 polymorphisms
###end title 19
###begin p 20
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
###xml 577 578 577 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
The SEPS1 polymorphisms (rs11327127, rs28665122, rs4965814, rs12917258, rs4965373 and rs2101171) were genotyped using TaqMan assays from Applied Biosystems following manufacturer's suggestions and analyzed in an ABI 7900HT Fast Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). Their location is indicated by the distance from the transcription start site: two of them are in the promoter region; another two in intron 5; rs4965373 depending of alternative splicing is either in intron 6 or in the 3'UTR region; and the last one is downstream at 9707 (see Table 1).
###end p 20
###begin p 21
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEL-S </italic>
###xml 76 84 <span type="species:ncbi:9606">patients</span>
Genotypic frequencies of the SEL-S polymorphisms in Spanish T1D, RA and IBD patients and controls.
###end p 21
###begin title 22
Statistical Analysis
###end title 22
###begin p 23
###xml 77 79 75 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 35 43 <span type="species:ncbi:9606">patients</span>
Allele and genotype frequencies in patients and controls were compared by chi2 test or Fisher exact test when necessary; p values were considered significant at a level of <0.05. Odds ratio (OR) and p values were calculated using a standard package (Epi Info v. 6.02, CDC, Atlanta, USA). For an OR = 1.5, the statistical power of our cohorts ranged from 80 - 95% depending on the specific polymorphism analyzed.
###end p 23
###begin p 24
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 227 229 227 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-7</sup>
Haplotypic frequencies were estimated using the Expectation-Maximization algorithm implemented in the Arlequin v2.000 software [20] with number of iterations set at 5000 and initial conditions at 50, with an epsilon value of 10-7.
###end p 24
###begin title 25
Results and discussion
###end title 25
###begin p 26
###xml 52 58 52 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
###xml 197 203 197 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
The present study investigates the influence of all SEPS1 variants previously correlated with increased pro-inflammatory cytokines levels (polymorphisms at -105G/A, 3705G/A and 5227C/T) and of the SEPS1 haplotypes on predisposition to inflammatory complex diseases.
###end p 26
###begin p 27
###xml 33 39 33 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
###xml 229 230 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 336 337 336 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 467 468 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 183 191 <span type="species:ncbi:9606">patients</span>
###xml 435 443 <span type="species:ncbi:9606">patients</span>
We first analyzed the functional SEPS1 promoter polymorphism at -105G/A and no significant differences in genotypic frequencies were observed when healthy controls were compared with patients suffering from T1D, RA or IBD (Table 1). As two other variants (rs4965814 and rs4965373) have been associated with high plasma cytokine levels [3], we studied them in our cohorts, and the distribution of genotypes followed the same pattern in patients and in controls (Table 1).
###end p 27
###begin p 28
###xml 96 97 96 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 376 377 376 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
We selected three additional polymorphisms along the gene from those described by Curran et al [3] in order to analyze the haplotypes inferred by applying the Expectation-Maximization algorithm implemented in the Arlequin software. No significant difference in haplotype frequencies was observed after appropriate correction for multiple testing in any diseased cohort (Table 2).
###end p 28
###begin p 29
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
###xml 112 120 <span type="species:ncbi:9606">patients</span>
Haplotypes estimated within the SEPS1 gene (alleles at -538/-105/3705/4283/5227/9707) and their distribution in patients and healthy individuals.
###end p 29
###begin p 30
###xml 50 56 50 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
###xml 329 330 329 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 472 474 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 545 551 541 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
###xml 733 739 729 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
###xml 601 609 <span type="species:ncbi:9606">patients</span>
###xml 785 793 <span type="species:ncbi:9606">patients</span>
A direct functionality has been attributed to the SEPS1 promoter polymorphism at -105G/A, increasing plasma levels of the aforementioned cytokines presumably due to the disruption of an ER stress element (ERSE). Two other tested variants have also been strongly related with the circulating levels of the inflammatory cytokines [3]. In contrast, a recent report did not find consistent association of this polymorphism with circulating levels of either IL-6 or TNF-alpha [21]. We did not observe differences in the genotypic distribution of the SEPS1 polymorphisms analyzed in Spanish cohorts between patients suffering from autoimmune diseases with a clear inflammatory component, like T1D, RA or IBD, and controls. The analysis of SEPS1 haplotypic frequencies did not differ between patients and healthy individuals either.
###end p 30
###begin p 31
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 217 223 217 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
###xml 447 448 447 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 125 130 <span type="species:ncbi:10090">mouse</span>
###xml 140 145 <span type="species:ncbi:9606">human</span>
Given that evidences exist for the affected expression and activity of some selenoproteins depending on sexual dimorphism in mouse [22] and human [23], we decided to check for a gender specific association of -105G/A SEPS1 polymorphism with the autoimmune disorders under study; however, we did not detect a gender-bias in our results. No significant difference between sex-stratified cohorts was found for any of the polymorphisms studied (Table 3).
###end p 31
###begin p 32
###xml 24 30 24 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
###xml 55 63 <span type="species:ncbi:9606">patients</span>
Genotype frequencies of SEPS1 polymorphisms in Spanish patients stratified by gender.
###end p 32
###begin p 33
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 427 433 427 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
###xml 550 556 550 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
###xml 913 915 913 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 976 982 976 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
###xml 1101 1107 1101 1107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
###xml 1170 1172 1170 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 85 91 <span type="species:ncbi:10090">murine</span>
###xml 134 142 <span type="species:ncbi:9606">patients</span>
SEPS1 expression was not significantly altered in intestinal epithelial cells of IBD murine models or in intestinal biopsies from IBD patients when compared with that present in controls [24]. Concordantly, a study testing the association of the promoter variant at -105 with cerebrovascular disease found no influence on stroke risk [25]. Both studies are in agreement with our results that showed lack of association between SEPS1 polymorphisms and susceptibility to chronic inflammatory diseases. Moreover, a Finnish study of five variants in the SEPS1 gene locus showed no significant difference between carriers/non-carriers when cardiovascular cases and healthy individuals were compared. The authors suggested that two polymorphisms contribute to the risk for coronary heart disease and for ischemic stroke in females; interestingly, the associated polymorphisms do not correspond with the one at -105G/A [21]. Therefore, evidences are mounting against the role of the SEPS1 gene in all these conditions, with the only exception to this point of one report defining the minor allele at -105G/A SEPS1 as a risk factor for preeclampsia in a large Norwegian cohort [26].
###end p 33
###begin title 34
Conclusion
###end title 34
###begin p 35
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 274 280 274 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
###xml 474 480 474 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEPS1 </italic>
The Wellcome Trust Case Control Consortium published recently a genome wide association study for several inflammatory conditions, such as RA, T1D or CD [27] Although the chromosomal region where the gene maps did not show association for any of the mentioned diseases, the SEPS1 polymorphisms were not analyzed and therefore their involvement in susceptibility could not be formally excluded. Ours is a thorough study analyzing the influence of six polymorphisms along the SEPS1 gene on susceptibility to common diseases, unravelling lack of association. Our data allow discardind a major individual role of this gene in the aetiology of the studied polygenic diseases.
###end p 35
###begin title 36
Abbreviations
###end title 36
###begin p 37
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SelS(SEPS1)</italic>
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>SelS(SEPS1)</italic></bold>
###xml 35 45 35 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(IL)-1&#946;</bold>
###xml 67 76 64 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TNF-&#945;</bold>
###xml 107 111 100 104 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IL-6</bold>
###xml 128 130 121 123 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ER</bold>
###xml 155 160 148 153 <bold xmlns:xlink="http://www.w3.org/1999/xlink">HepG2</bold>
###xml 210 213 203 206 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RNA</bold>
###xml 233 237 226 230 <bold xmlns:xlink="http://www.w3.org/1999/xlink">SAAs</bold>
###xml 277 279 270 272 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RA</bold>
###xml 303 305 296 298 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MS</bold>
###xml 327 330 320 323 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IBD</bold>
###xml 361 366 354 359 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IDDM3</bold>
###xml 407 410 400 403 <bold xmlns:xlink="http://www.w3.org/1999/xlink">T1D</bold>
###xml 429 431 422 424 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CD</bold>
###xml 450 452 443 445 <bold xmlns:xlink="http://www.w3.org/1999/xlink">UC</bold>
###xml 474 478 467 471 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ERSE</bold>
###xml 499 502 492 495 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ADA</bold>
###xml 535 538 528 531 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ACR</bold>
###xml 574 576 567 569 <bold xmlns:xlink="http://www.w3.org/1999/xlink">L1</bold>
###xml 593 595 586 588 <bold xmlns:xlink="http://www.w3.org/1999/xlink">L2</bold>
###xml 614 616 607 609 <bold xmlns:xlink="http://www.w3.org/1999/xlink">L3</bold>
###xml 639 641 632 634 <bold xmlns:xlink="http://www.w3.org/1999/xlink">L4</bold>
###xml 681 683 674 676 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B1</bold>
###xml 716 718 709 711 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B2</bold>
###xml 750 752 743 745 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B3</bold>
###xml 784 786 777 779 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OR</bold>
###xml 800 803 793 796 <bold xmlns:xlink="http://www.w3.org/1999/xlink">FIS</bold>
###xml 162 167 <span type="species:ncbi:9606">Human</span>
SelS(SEPS1): Selenoprotein S gene; (IL)-1beta: Interleukin 1 beta; TNF-alpha: Tumor necrosis factor alpha; IL-6: Interleukin 6; ER: Endoplasmic reticulum; HepG2: Human hepatocellular liver carcinoma cell line; RNA: Ribonucleic acid; SAAs: Acute phase serum amyloid A proteins; RA: Rheumatoid arthritis; MS: Multiple sclerosis; IBD: Inflammatory bowel diseases; IDDM3: Insulin-dependent diabetes mellitus 3; T1D: Type 1 diabetes; CD: Crohn's disease; UC: Ulcerative colitis; ERSE: ER stress element; ADA: American Diabetes Association; ACR: American College of Rheumatology; L1: Ileal lesions; L2: Colonic lesions; L3: Ileocolonic lesions; L4: Upper gastrointestinal tract lesions; B1: Inflammatory disease behavior; B2: Structuring disease behavior; B3: Perforating disease behavior; OR: Odds ratio; FIS: Fondo de Investigaciones Sanitarias.
###end p 37
###begin title 38
Authors' contributions
###end title 38
###begin p 39
###xml 51 59 <span type="species:ncbi:9606">patients</span>
JLS, JV and AnM, carried out the genotyping of the patients and a great part of the controls, participated in the statistical analysis and drafted the manuscript. JLM, HdlC, MDR, JRL and BFG made the diagnosis and collaborated in collection of samples. AM participated in the coordination of the study and participated in the statistical analysis. EGdlC coordinated the study and critically revised the manuscript. EU conceived of the study, participated in the statistical analysis and completed the writing of the manuscript. All authors read and approved the final manuscript.
###end p 39
###begin title 40
Acknowledgements
###end title 40
###begin p 41
The authors thank Carmen Martinez for her skilful technical assistance. Alfonso Martinez and Jose Luis Santiago hold research FIS contracts (CP04/00175 and CM05/00216, respectively). Jezabel Varade is a fellow and Elena Urcelay works for the "Fundacion para la Investigacion Biomedica-Hospital Clinico San Carlos". This work was supported by grants from: Fundacion Mutua Madrilena and Fundacion Ramon Areces.
###end p 41
###begin article-title 42
A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol
###end article-title 42
###begin article-title 43
Endoplasmicreticulum-induced signal transduction and gene expression
###end article-title 43
###begin article-title 44
Genetic variation in selenoprotein S influences inflammatory response
###end article-title 44
###begin article-title 45
Activation of the selenoprotein SEPS1 gene expression by pro-inflammatory cytokines in HepG2 cells
###end article-title 45
###begin article-title 46
Tanis: a link between type 2 diabetes and inflammation?
###end article-title 46
###begin article-title 47
###xml 158 166 <span type="species:ncbi:9606">patients</span>
Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis
###end article-title 47
###begin article-title 48
###xml 70 78 <span type="species:ncbi:9606">patients</span>
Serum amyloid A (SAA) concentration varies among rheumatoid arthritis patients estimated by SAA/CRP ratio
###end article-title 48
###begin article-title 49
###xml 27 42 <span type="species:ncbi:10090">transgenic mice</span>
Serum amyloid A-luciferase transgenic mice: response to sepsis, acute arthritis, and contact hypersensitivity and the effects of proteasome inhibition
###end article-title 49
###begin article-title 50
Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-kappaB-dependent signal transduction pathway
###end article-title 50
###begin article-title 51
Serum amyloid A protein is elevated in relapsing-remitting multiple sclerosis
###end article-title 51
###begin article-title 52
Serum amyloid A protein compared with C-reactive protein, alpha 1-antichymotrypsin and alpha 1-acid glycoprotein as a monitor of inflammatory bowel disease
###end article-title 52
###begin article-title 53
Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis
###end article-title 53
###begin article-title 54
###xml 51 59 <span type="species:ncbi:9606">patients</span>
Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis
###end article-title 54
###begin article-title 55
Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases
###end article-title 55
###begin article-title 56
Regulation of the selenoprotein SelS by glucose deprivation and endoplasmic reticulum stress - SelS is a novel glucose-regulated protein
###end article-title 56
###begin article-title 57
A locus on chromosome 15q26 (IDDM3) produces susceptibility to insulin-dependent diabetes mellitus
###end article-title 57
###begin article-title 58
Linkage of type I diabetes to 15q26 (IDDM3) in the Danish population
###end article-title 58
###begin article-title 59
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
###end article-title 59
###begin article-title 60
Classification of inflammatory bowel disease
###end article-title 60
###begin article-title 61
Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population
###end article-title 61
###begin article-title 62
Variation in the selenoprotein S gene locus is associated with coronary heart disease and ischemic stroke in two independent Finnish cohorts
###end article-title 62
###begin article-title 63
###xml 128 134 <span type="species:ncbi:10090">murine</span>
Selenium-dependent pre- and posttranscriptional mechanisms are responsible for sexual dimorphic expression of selenoproteins in murine tissues
###end article-title 63
###begin article-title 64
###xml 29 34 <span type="species:ncbi:9606">human</span>
Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study)
###end article-title 64
###begin article-title 65
The role of the selenoprotein S (SELS) gene -105G>A promoter polymorphism in inflammatory bowel disease and regulation of SELS gene expression in intestinal inflammation
###end article-title 65
###begin article-title 66
No association of the -105 promoter polymorphism of the selenoprotein S encoding gene SEPS1 with cerebrovascular disease
###end article-title 66
###begin article-title 67
Genetic association of preeclampsia to the inflammatory response gene SEPS1
###end article-title 67
###begin article-title 68
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
###end article-title 68

